Faculty
Andrew Zelenetz
MD, PhD
2026 Sessions
Mini Symposium: Advances in Precision Therapy in CLL: Integrating BTK and BCL-2 Inhibition Across the Treatment Continuum
-
Invited Speaker
- John Allan
- Andrew Zelenetz
- Andrew Zelenetz
Back to top